GeneDx Holdings Corp (WGS)
19.61
-0.78
(-3.83%)
USD |
NASDAQ |
May 31, 16:00
19.66
+0.05
(+0.25%)
After-Hours: 20:00
GeneDx Holdings Cash from Operations (TTM): -141.00M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -141.00M |
December 31, 2023 | -180.15M |
September 30, 2023 | -214.94M |
June 30, 2023 | -262.08M |
March 31, 2023 | -293.22M |
Date | Value |
---|---|
December 31, 2022 | -319.16M |
September 30, 2022 | -306.49M |
June 30, 2022 | -289.06M |
March 31, 2022 | -229.72M |
December 31, 2021 | -190.43M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-319.16M
Minimum
Dec 2022
-141.00M
Maximum
Mar 2024
-242.62M
Average
-245.90M
Median
Cash from Operations (TTM) Benchmarks
GE HealthCare Technologies Inc | 2.052B |
Spok Holdings Inc | 25.57M |
Ontrak Inc | -13.80M |
DarioHealth Corp | -38.73M |
FOXO Technologies Inc | -10.69M |